Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00585338 · ClinicalTrials.gov registry record · Phase 1
Treatment of Vascular Lesions With a Tandem 532/1064 nm Laser
A Phase 1 study of Vascular Lesion, sponsored by University of California, Irvine.
- Completed
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
- 1
- Study location
NCT00585338 is a Phase 1 study of Vascular Lesion that has completed, run by University of California, Irvine. The registered enrollment target is 1 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00585338, a Phase 1 study of Vascular Lesion, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
- 1
- Study location
Study Summary
Dermatologists have for many years treated vascular lesions by a variety of modalities including cryosurgery, electrotherapy, dermabrasion and radiation. It has been hypothesized that simultaneous delivery of these two wavelengths may provide safer, and in some cases more effective, vascular lesion removal. The Tandem laser is capable of emitting multiple cryogen spurts intermittently with multiple 532/1064 nm laser pulses.This mode may reduce malformed blood vessels with a low incidence of long-term side effects.
Conditions Studied
Interventions
- DEVICE Tandem 532/1064 nm Laser
Study Locations (1)
California
- Beckman Laser Institute Medical and Surgical Clinic - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2007-12 |
| Est. Completion | 2010-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00585338
The ClinicalTrials.gov registry entry for NCT00585338 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Vascular Lesion appearing as the primary indexed condition, and to 1 intervention - of which Tandem 532/1064 nm Laser is the first listed.
NCT00585338 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00585338 about?
NCT00585338 is a clinical study titled "Treatment of Vascular Lesions With a Tandem 532/1064 nm Laser". Dermatologists have for many years treated vascular lesions by a variety of modalities including cryosurgery, electrotherapy, dermabrasion and radiation. It has been hypothesized that simultaneous delivery of these two wavelengths may provide safer, and in some cases more effective, vascular lesion...
What is the current status of trial NCT00585338?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2007-12. Estimated completion is 2010-10.
What conditions does trial NCT00585338 study?
This clinical trial studies the following conditions: Vascular Lesion.
What interventions are being tested in trial NCT00585338?
The interventions under investigation include: Tandem 532/1064 nm Laser (DEVICE).
Who is sponsoring clinical trial NCT00585338?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00585338 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vascular Lesion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.